Yunji Soars on Narrower Loss; Ginkgo Bioworks, Xcel Energy Downgraded
- June 02nd, 2023
- 255 views
Yunji Inc. (Nasdaq: YJ) experienced a significant surge in its stock price as the company reported a narrower loss in its financial results.
In the first quarter of 2023, Yunji recorded a net loss of RMB22.9 million (US$3.3 million), representing a substantial improvement of 37.9% compared to the net loss of RMB36.9 million in the same period of the previous year.
$YJ was trading at $0.40 in pre-market, up $0.18 (+88.59%)
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) faced a downgrade in its rating from Neutral to Sell by Goldman Sachs, accompanied by a significant decrease in its price target from $3 to $1.25.
During pre-market, $DNA was trading at $1.60, down $0.07 (-4.46%).
Similarly, Xcel Energy Inc. (Nasdaq: XEL) experienced a downgrade in its rating from Overweight to Neutral by JP Morgan, along with a lowered price target from $79 to $68. Wolfe Research also downgraded XEL from Outperform to Peer Perform.
$XEL was trading at $62.18 in pre-market, showing a decrease of $1.37 (-2.16%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login